Recently, green tea extract and gallic acid showed antioxidant potential in murine models of post-stroke depression, evaluated by GSH, SOD, and thiobarbituric acid-reactive substance (TBARS) (Lorenzo et al
Disclosures: Jasmine Ahmed: Nothing to Disclose, Deanna Oliver: Nothing to Disclose, Yaseen Kady: Nothing to Disclose, Julian Diaz-Moreno: Nothing to Disclose, James Johnson: Nothing to Disclose, Eric Storey: Nothing to Disclose, Maryam Yasso: Nothing to Disclose, Anna Hefner: Nothing to Disclose, Tarek Hassanein: Nothing to Disclose 447 INCIDENCE OF HEPATITIS DELTA VIRUS SUPER-INFECTION IN HBSAG POSITIVE PATIENTS FROM FRANCE AND THE GAMBIA (THE INCI-D COHORT STUDY) Patrick INGILIZ 1 Erwan Vo Quang 2 Maud Lemoine 3 Amie Ceesay 4 Gibril Ndow 5 Marie-Noelle Hilleret 6 Laure Bordy 7 Thomas Decaens 6 Anne-Laure Mazialivoua 8 Yusuke Shimakava 9 Alhagie Bakoteh 5 Jean-Michel Pawlotsky 10 Isabelle CHEMIN 4 Stphane Chevaliez 11 Vincent Leroy 8 , 1 APHP Henri-Mondor University Hospital, 2 INSERM U955, Crteil, France, MRC The Gambia Unit@London School of Hygiene and Tropical Medicine, F, 3 Imperial College London, London, UK, 4 Cancer Research Centre, INSERM, Lyon, France, 5 MRC The Gambia Unit@London School of Hygiene and Tropical Medicine, Fajara, The Gambia, 6 University Hospital Grenoble-Alpes, Hepatology Department, Grenoble, France, 7 [email protected], 8 APHP Henri-Mondor University Hospital, Hepatology Department, Crteil, France, 9 Unit d'pidmiologie des Maladies mergentes, Institut Pasteur, Paris, France, 10 INSERM U955, Crteil, France, 11 INSERM U955 Background: Super- infection with the hepatitis D virus (HDV) leads to a more aggressive form of chronic hepatitis in patients infected with the hepatitis B virus (HBV)
In a dedicated analysis of data from the United States Food and Drug Administrations Adverse Event Reporting System [76], the rate of rhabdomyolysis was 0.58 cases per million prescriptions for fenofibrate combined with any statin other than cerivastatin (a statin with a high risk of rhabdomyolysis that was taken out of the market), as compared to 8.6 cases per million prescriptions for gemfibrozil in the same combination
Fructose 1,6-bisphosphatase as a promising target of anticancer treatment
